Publications by authors named "Jonas B Vischedyk"

Claim this Profile
R
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf, Jonas B Vischedyk

Eur J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia.
Laura M Meyer, Sebastian E Koschade, Jonas B Vischedyk, Marlyn Thoelken, Andrea Gubas

Autophagy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Rewiring Is Essential for AML Cell Survival to Overcome Autophagy Inhibition by Loss of ATG3.
Fatima Baker, Ibrahim H Polat, Khalil Abou-El-Ardat, Islam Alshamleh, Marlyn Thoelken, Jonas B Vischedyk

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9-based target validation for p53-reactivating model compounds.
Michael Wanzel, Jonas B Vischedyk, Miriam P Gittler, Niklas Gremke, Julia R Seiz

Nat Chem Biol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases.
Joël P Charles, Jeannette Fuchs, Mirjam Hefter, Jonas B Vischedyk, Maximilian Kleint

Nat Commun· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis